Science
Bank of America is dropping $250+ million on GLP-1s annually
In recruiting, GLP-1 coverage could be the new unlimited PTO or wellness stipend.
Pharmaceutical Pricing & Access
Your source for everything pharmaceutical pricing & access, featuring the latest updates, industry context, and expert perspectives from Morning Brew.
Science
Generic Ozempic is coming to billions of people
Once Novo Nordisk's patent expires, about 50 generic semaglutide brands are expected to enter India alone, some as soon as this weekend.
Science
Is banning pharmaceutical TV ads right for you?
President Trump signed a memo that could get drug commercials off the air
Science
FDA says shortage of weight loss drug ingredients is over, compounders are nervous
The compounding of drugs is a fairly common practice to make customized copy-cat versions of brand-name drugs.
Science
Novo Nordisk CEO’s Senate showdown
Novo Nordisk’s executive faced off with Sen. Bernie Sanders in a hearing over the high cost of its so-called “miracle” drugs, Ozempic and Wegovy.
Science
Study: A month’s supply of Ozempic costs under $5 to make
Last year, Wegovy’s and Ozempic’s combined sales brought in over $18 billion for Novo.
Science
Eli Lilly is the new Tesla
The drugmaker is riding high on its weight loss and diabetes products.
Become smarter in just 5 minutes
Morning Brew delivers quick and insightful updates about the business world every day of the week from Wall St. to Silicon Valley.
By subscribing, you accept our Terms & Privacy Policy.
